Plus Therapeutics (PSTV) Institutional Ownership → Central Bank Gold Heist In Progress (From Colonial Metals) (Ad) Free PSTV Stock Alerts $1.72 -0.01 (-0.58%) (As of 03/18/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Plus Therapeutics (NASDAQ:PSTV)CurrentInstitutional OwnershipPercentage3.54%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$895,516.20Number ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$493,677.22 Get PSTV Insider Trade Alerts Want to know when executives and insiders are buying or selling Plus Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data PSTV Institutional Buying and Selling by Quarter Ad Prosper Trading AcademyDid you make $29,000 two days with AI options trades?What if it was possible to find options trades on autopilot… Using A.I. to find the ones with the highest profit potential… And nearly perfect win rates… You can grab your free copy of my "Ultimate Guide to A.I. Options Trading" by clicking the link below:Click Here To Get Your Free Copy Plus Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails3/11/2024Vanguard Group Inc.32,541$57K0.0%+100.9%0.760% 2/15/2024Vanguard Group Inc.32,541$57K0.0%+100.9%0.720% 2/15/2024Citadel Advisors LLC16,839$30K0.0%N/A0.373% 8/11/2023Geode Capital Management LLC17,007$34K0.0%-93.3%0.694% 5/16/2023Geode Capital Management LLC255,148$74K0.0%-1.1%10.427% 5/12/2023Renaissance Technologies LLC264,310$77K0.0%+237.3%10.801% Get the Latest News and Ratings for PSTV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Plus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/15/2023Schonfeld Strategic Advisors LLC190,400$60K0.0%N/A0.567% 2/15/2023Millennium Management LLC136,903$43K0.0%+1,003.8%0.407% 11/15/2022Vanguard Group Inc.1,092,568$0.49M0.0%+27.7%3.252% 11/15/2022Parkman Healthcare Partners LLC1,325,025$0.59M0.2%-13.6%3.943% 11/14/2022Renaissance Technologies LLC70,900$32K0.0%-29.9%0.211% 8/13/2022Renaissance Technologies LLC101,093$55K0.0%+50.1%0.449% 8/8/2022Otter Creek Advisors LLC330,168$0.18M0.1%+293.5%1.465% 5/13/2022Renaissance Technologies LLC67,358$67K0.0%-67.4%0.303% 5/13/2022Parkman Healthcare Partners LLC1,526,316$1.53M0.4%N/A6.875% 5/13/2022Vanguard Group Inc.855,264$0.86M0.0%+20.0%3.853% 5/9/2022Otter Creek Advisors LLC83,901$84K0.0%N/A0.378% 11/9/2021BlackRock Inc.128,323$0.25M0.0%-19.7%0.835% 9/17/2021Virtu Financial LLC76,187$0.20M0.0%N/A0.630% 8/16/2021State Street Corp34,214$88K0.0%N/A0.283% 8/13/2021Renaissance Technologies LLC17,607$45K0.0%N/A0.146% 8/13/2021Northern Trust Corp40,524$0.10M0.0%N/A0.335% 8/13/2021Geode Capital Management LLC130,793$0.33M0.0%N/A1.082% 8/13/2021Vanguard Group Inc.712,847$1.83M0.0%+824.7%5.897% 8/12/2021Dimensional Fund Advisors LP68,430$0.18M0.0%N/A0.566% 8/11/2021Susquehanna Fundamental Investments LLC13,033$33K0.0%N/A0.108% 2/24/2021Virtu Financial LLC18,318$37K0.0%-16.5%0.383% 2/10/2021Renaissance Technologies LLC106,100$0.21M0.0%+202.7%2.220% 1/29/2021Creative Planning13,856$28K0.0%N/A0.290% 12/11/2020Virtu Financial LLC21,932$56K0.0%N/A0.459% 2/14/2020 Bank of New York Mellon Corp28,763$69K0.0%N/A0.763% 2/13/2020Oxford Asset Management LLP20,742$50K0.0%N/A0.550% 2/13/2020Renaissance Technologies LLC85,634$0.21M0.0%+146.6%2.271% (Data available from 1/1/2016 forward) PSTV Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PSTV shares? During the previous two years, the following institutional investors and hedge funds held shares of Plus Therapeutics shares: Parkman Healthcare Partners LLC ($0.59M), Otter Creek Advisors LLC ($0.18M), Renaissance Technologies LLC ($77K), Schonfeld Strategic Advisors LLC ($60K), Vanguard Group Inc. ($57K), Millennium Management LLC ($43K), and Geode Capital Management LLC ($34K).Learn more on PSTV's institutional investors. What percentage of Plus Therapeutics stock is owned by institutional investors? 3.54% of Plus Therapeutics stock is owned by institutional investors. Learn more on PSTV's institutional investor holdings. Which institutional investors have been buying Plus Therapeutics stock? The following institutional investors have purchased Plus Therapeutics stock in the last 24 months: Parkman Healthcare Partners LLC ($1.53M), Vanguard Group Inc. ($0.41M), Otter Creek Advisors LLC ($0.33M), Renaissance Technologies LLC ($0.22M), Schonfeld Strategic Advisors LLC ($0.19M), Millennium Management LLC ($0.12M), and Citadel Advisors LLC ($16.84K). How much institutional buying is happening at Plus Therapeutics? Institutional investors have bought a total of 2,820,307 shares in the last 24 months. This purchase volume represents approximately $32.53M in transactions. Which Plus Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Plus Therapeutics stock in the last 24 months: Geode Capital Management LLC ($0.24M), Parkman Healthcare Partners LLC ($0.21M), and Renaissance Technologies LLC ($0.17M). How much institutional selling is happening at Plus Therapeutics? Institutional investors have sold a total of 618,430 shares in the last 24 months. This volume of shares sold represents approximately $4.17M in transactions. Related Companies: NeuroMetrix Institutional Ownership Vapotherm Institutional Ownership Vivos Therapeutics Institutional Ownership PolyPid Institutional Ownership Minerva Surgical Institutional Ownership ProSomnus Institutional Ownership Intelligent Bio Solutions Institutional Ownership Acutus Medical Institutional Ownership Sharps Technology Institutional Ownership Aethlon Medical Institutional Ownership This page (NASDAQ:PSTV) was last updated on 3/18/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial MetalsLike Tiny Crypto Retirement FundsCrypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyThe world’s greatest investmentPorter & CompanyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingStock-Picking AI Predicts #1 Stock of 2024AltimetrySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Plus Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.